Microbot Medical records first revenue from LIBERTY; Q2 revenue already exceeds Q1

Microbot Medical Inc.

Recorded revenue from limited market release of LIBERTY System in Q1 2026; transitioned to full market release in Q2.
Q2 revenue mid-way through quarter already exceeds total Q1 revenue; accounts more than doubled since LMR ended.
Hospitals in six states (GA, FL, NY, MI, MA, NC) have adopted the system; Boston now has multiple accounts.
First robotic procedures include PAE for BPH, GAE for knee pain, and Y-90 radioembolization for liver cancer.
Growth supported by updated occupational radiation guidelines from nine medical societies including AMA.

item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-022886
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-05-14T12:30:25+00:00
discovered_at: 2026-05-14T12:35:00.354772+00:00
generated_at: 2026-05-14T12:36:53.077535+00:00
sec_items: ["7.01", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.65
confidence: medium
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-022886
json_url: https://secwatch.observer/filing/0001493152-26-022886.json
markdown_url: https://secwatch.observer/filing/0001493152-26-022886.md
text_url: https://secwatch.observer/filing/0001493152-26-022886.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226022886/0001493152-26-022886-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226022886/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-022886

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.